Information  X 
Enter a valid email address

Proteome Sciences PLC Ord 1P (PRM)

Related News

26-Mar-2021 09:10 AM

Proteome Sciences revises up profit after tax forecast

Biomarker developer Proteome Sciences has said that it now expects to report profit after tax 'materially higher' than announced on 25 January. The directors of the company said this is primarily due to higher-than-expected royalty receipts fro
25-Jan-2021 08:45 AM

Proteome Sciences profit to fall on flat revenue, higher costs

Biomarker discovery group Proteome Sciences said it expected to report a modest fall in annual profit as costs rose. Pre-tax profit for the year through December was expected to decrease to £0.03 million, down from £0.2 million year-on-year.
10-Aug-2020 07:56 AM

Proteome Sciences posts first-half loss as pandemic disrupts laboratory access

Biomarker company Proteome Sciences posted a first-half loss after a rise in revenue was offset by increased expenses. Pre-tax losses for the six months through June amounted to £484k, compared to losses of £410k. Revenue rose 9.1% to £
26-Jun-2020 01:27 PM

Proteome Sciences services revenue up in year to date

Biomarker developer Proteome Sciences said it had experienced 'good' growth in services revenue over the first five months of the year. Sales of the company's TMT and TMTpro products, meanwhile, had remained stable. 'Despite the chal
14-Apr-2020 09:24 AM

Proteome Sciences swings to profit; broadly unaffected by Covid-19 crisis

Biomarker company Proteome Sciences swung to a full-year profit and said its revenue in the first quarter of the new financial year had been broadly unaffected by the Covid-19 crisis. Net profit for the year through December amounted to £0.15m, com
11-Feb-2020 07:58 AM

Proteome Sciences to swing to profit as sales jump 57%

Protein biomarker developer Proteome Sciences said it expected to swing to a full-year profit after recording stronger-than-expected sales in the fourth quarter. Net profit for the year through December was expected at around £0.2m, compared to a l
21-Jan-2020 09:27 AM

Proteome Sciences expects to narrow losses as sales rise 24%

Medical services group Proteome Sciences said it expected to narrow its losses after its revenue rose and operating costs fell. Net losses for the year through December were seen at around £0.5m, compared to losses of £1.3m on-year. Revenue
23-Jan-2019 08:30 AM

Proteome Sciences expects losses to narrow on cost cutting

Proteome Sciences said its annual revenue fell by 11%, though cost cutting mean it would narrow its losses. Revenue for the year through December was expected to fall to around £3.0m, as costs fell 12%. Net losses were expected to narrow to around
06-Nov-2018 09:50 AM

Proteome Sciences expects annual loss amid disappointing sales performance

Biomarker group Proteome Sciences warned it expected to report a full-year operating loss similar in size to 2017, as its revenue performance remained behind plan. Full-year services revenues were expected to be in line with the previous year, reflecting
24-Jul-2018 07:54 AM

Proteome Sciences posts first-half loss after revenue falls

Protein bio-market discovery group Proteome Sciences posted a first-half loss after revenue fell. Pre-tax losses for the six months through June amounted to £1.41m, narrowing from £1.80m on-year. Revenue fell 3% to £1.32m, while admini
30-May-2018 02:12 PM

Proteome Sciences says first-quarter trading soft as expected

Biomarker developer Proteome Sciences said trading so far in 2018 was 'broadly in line' with expectations amid a characteristically slow first quarter. 'As stated in our recent results, we expect 2018 to be a year of progress as we develop
24-Apr-2018 09:20 AM

Proteome Science losses narrow as sales grow

Biomarker provider Proteome Sciences said annual pre-tax losses narrowed to around £2.0m, from £2.0m a year earlier. Revenue grew 23% to £3.4m, underpinned by a 79% increase in sales and royalties for the company's reagents. At
12-Feb-2018 09:00 AM

Broker Forecast - finnCap issues a broker note on Proteome Sciences PLC

finnCap today reaffirms its corporate investment rating on Proteome Sciences PLC (LON:PRM) and set its price target at 7p. Story provided by Broker Forecasts data provided by
12-Feb-2018 08:05 AM

Proteome Sciences losses narrow as revenue rises, costs fall

Proteome Sciences said it expected its annual losses to narrow as revenue rose and costs fell. Losses before tax would be around £2.1m, compared to £2.9m in 2016, the company said. Revenue increased by 18%, while costs fell by 5%. Cash rese
01-Sep-2017 01:01 PM

Proteome issues shares

Proteome Sciences confirmed that it has issued and allotted 533,333 ordinary shares as payment for professional services. At 1:01pm: (LON:PRM) Proteome Sciences PLC share price was 0p at 3.62p Story provided by
11-Jul-2017 01:25 PM

Proteome schedules interim results release date

Proteome Sciences has confirmed that the Company will announce its interim results for the six months ended 30 June on 25 July. At 1:25pm: (LON:PRM) Proteome Sciences PLC share price was -0.05p at 3.88p Story provided by
15-Sep-2016 07:10 AM

Proteome Sciences revenues up

Proteome Sciences said revenues to 30 June increased 32% to £1.12 million (2015: £0.85 million). Licences/sales/services revenues increased 44% to £1.08m (2015: £0.75m), while TMT reagent sales increased 27%. Administrative expen
01-Dec-2014 03:28 PM

Proteome Sciences appoints company secretary

Proteome Sciences has confirmed that James Malthouse has, as announced on 30 September, retired today as a director and as company secretary. Finance director Geoffrey Ellis has been appointed as company secretary. At 3:28pm: (LON:PRM) Proteome Science
12-Nov-2014 09:21 AM

Proteome contract delays

Proteome Sciences said anticipated contract delays means revenue for the current year will be lower than market expectations and somewhat lower than the revenues achieved in 2013. The delayed revenues were expected to be booked in 2015, supported by str
25-Sep-2014 10:24 AM

Preotome Sciences signs $2m research contract

Proteome Sciences has signed a $2m contract with Genting TauRx Diagnostic Centre to develop diagnostic panels to detect Alzheimer's disease and monitor treatment efficacy. Its PS Biomarker Services Division ("PS") has been selected to deve
07-Feb-2014 07:23 AM

Proteome Sciences sees FY revenue up significantly

Proteome Sciences said revenue for 2013 is expected be significantly higher than in 2012 due to the strong performances across its core activities. "The Orbitrap Fusion mass spectrometer provided as part of the licensing deal with Thermo Fisher Sci
04-Dec-2013 07:30 AM

Proteome says some contract revenue delayed beyond Q4

Proteome Sciences sales lead times however have taken longer than anticipated and the timing and revenue from a number of other contracts expected in the fourth quarter has been delayed and is now projected to fall into 2014. "Our pipeline and the
30-Sep-2013 08:56 AM

Proteome Sciences H1 pretax loss widens to £1.9m

Proteome Sciences' H1 pretax loss widened to £1.9m, from a loss of £1.7m. Total revenue was £0.89m, from £0.81m. "Our core activities are performing well and we hope to show a considerable increase in revenue for the full year with that perf
18-Sep-2013 02:17 PM

Proteome Sciences presents data at HUPO

Proteome Sciences presented novel data and key assay developments at the HUPO 12th Annual World Congress in Japan. The data covered Tau in Alzheimer's disease, SysQuant in pancreatic cancer and a missing isoform in sugar structures of clusterin, a p
06-Aug-2013 12:41 PM

Shares issue at Proteome Sciences raises £1.57m

Proteome Sciences has received a direct approach from an institutional investor to subscribe for 3,750,000 new ordinary shares at a price of 41.5p per share. The issue raised approximately £1.57m which will be used as additional working capital to dev
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t